BeOne Medicines' sonrotoclax granted FDA Priority Review for relapsed or refractory mantle cell lymphoma

AstraZeneca wins US approval for Imfinzi as first perioperative immunotherapy in early gastric and GEJ cancer

Curasight begins phase 1 trial of uTREAT in glioblastoma

Prestige Biopharma agrees Tuznue licence and supply deal for Latin America

Lunai Bioworks receives first LOI to license next-generation immune cell therapy

Active Biotech to receive US patent for tasquinimod formulation

AstraZeneca to invest USD2bn in major Maryland manufacturing expansion

Vaximm enters non-binding term sheet with BCM Europe

Abbott agrees to acquire Exact Sciences

Nuvalent's zidesamtinib NDA filing accepted by US FDA

Hemispherian secures US patent allowance expanding GLIX1 patent protection

AbbVie receives approval for EPKINLY, rituximab and lenalidomide combination

Genentech reports first oral SERD to improve invasive disease-free survival in early breast cancer

Biotheryx completes enrolment in ongoing Phase 1a trial of BTX-9341 for HR+/HER2- breast cancer

Galmed Pharmaceuticals reports topline results for combination of Aramchol, Stivarga and metformin